Literature DB >> 36068841

Structural chemistry and molecular-level interactome reveals histidine kinase EvgS to subvert both antimicrobial resistance and virulence in Shigella flexneri 2a str. 301.

Aniket Naha1,2, Sudha Ramaiah1,3.   

Abstract

Multi-drug resistant (MDR) Shigella flexneri 2a, one of the leading bacterial agents of diarrhoeal mortality, has posed challenges in treatment strategies. The present study was conducted to identify potential therapeutic biomarkers using gene interaction network (GIN) in order to understand the cellular and molecular level interactions of both antimicrobial resistance (AMR) and virulence genes through topological and clustering metrics. Statistically significant differential gene expression (DGE), structural chemistry and dynamics were incorporated to elucidate biomarker for sustainable therapeutic regimen against MDR S. flexneri. Functional enrichments and topological metrics revealed evgS, ybjZ, tolC, gyrA, parC and their direct interactors to be associated with diverse AMR mechanisms. Histidine kinase EvgS was considered as the hub protein due to its highest prevalence in the molecular interactome profiles of both the AMR (71.6%) and virulence (45.8%) clusters interconnecting several genes concerning two-component system (TCS). DGE profiles of ΔPhoPQ (deleted regulatory PhoP and sensor PhoQ) led to the upregulation of TCS comprising EvgSA thereby validating EvgS as a promising therapeutic biomarker. Druggability and structural stability of EvgS was assessed through thermal shifts, backbone stability and coarse dynamics refinement. Structure-function relationship was established revealing the C-terminal extracellular domain as the drug-binding site which was further validated through molecular dynamics simulation. Structure elucidation of identified biomarker followed by secondary and tertiary structural validation would prove pivotal for future therapeutic interventions against subverting both AMR and virulence posed by this strain. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-022-03325-w. © King Abdulaziz City for Science and Technology 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Entities:  

Keywords:  Differential gene expression; Druggability; Gene interaction network; Molecular Dynamics Simulation; Protein Modelling; Shigella flexneri 2a str. 301

Year:  2022        PMID: 36068841      PMCID: PMC9440972          DOI: 10.1007/s13205-022-03325-w

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  72 in total

Review 1.  Inhibitors of bacterial two-component signalling systems.

Authors:  M J Macielag; R Goldschmidt
Journal:  Expert Opin Investig Drugs       Date:  2000-10       Impact factor: 6.206

2.  Molecular diagnosis of non-serotypeable Shigella spp.: problems and prospects.

Authors:  Dhiviya Prabaa Muthuirulandi Sethuvel; Naveen Kumar Devanga Ragupathi; Shalini Anandan; Kamini Walia; Balaji Veeraraghavan
Journal:  J Med Microbiol       Date:  2017-02       Impact factor: 2.472

3.  Comparative Protein Structure Modeling Using MODELLER.

Authors:  Benjamin Webb; Andrej Sali
Journal:  Curr Protoc Bioinformatics       Date:  2016-06-20

Review 4.  Update on: Shigella new serogroups/serotypes and their antimicrobial resistance.

Authors:  D P Muthuirulandi Sethuvel; N K Devanga Ragupathi; S Anandan; B Veeraraghavan
Journal:  Lett Appl Microbiol       Date:  2016-11-28       Impact factor: 2.858

Review 5.  The roles of two-component systems in virulence of pathogenic Escherichia coli and Shigella spp.

Authors:  Toru Tobe
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

6.  Molecular, genetic, and topological characterization of O-antigen chain length regulation in Shigella flexneri.

Authors:  R Morona; L van den Bosch; P A Manning
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

7.  Cytoscape 2.8: new features for data integration and network visualization.

Authors:  Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Trey Ideker
Journal:  Bioinformatics       Date:  2010-12-12       Impact factor: 6.937

8.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

9.  GalaxyRefine: Protein structure refinement driven by side-chain repacking.

Authors:  Lim Heo; Hahnbeom Park; Chaok Seok
Journal:  Nucleic Acids Res       Date:  2013-06-03       Impact factor: 16.971

10.  Changing trends and serotype distribution of Shigella species in Beijing from 1994 to 2010.

Authors:  Yuanli Mao; Enbo Cui; Chunmei Bao; Zhenhong Liu; Suming Chen; Juling Zhang; Huan Wang; Chenglong Zhang; Jing Zou; John D Klena; Baoli Zhu; Fen Qu; Zhiyun Wang
Journal:  Gut Pathog       Date:  2013-08-07       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.